Westminster Health Forum

Antimicrobial resistance - progress on the UK strategy and coordinating a global response


This conference focuses on next steps for tackling antimicrobial resistance (AMR) in the UK - and the global response to AMR.

It will be an opportunity to assess priorities for improving infection prevention and control as stakeholders in health care and research begin implementation of Public Health England’s Infectious Disease Strategy 2020-2025

Areas for discussion include:

  • Supporting the infection prevention workforce;
  • Developing innovative diagnostic technologies;
  • Reducing the transmission of resistant bacteria; and.
  • The Strategy’s goal to make the UK a world leader in tackling AMR.

Further sessions will consider the progress of research into AMR, with discussion on funding, impact and supporting innovation to address AMR in humans, animals, and the environment.

The agenda includes keynote addresses from:

  • Professor Hanan Balkhy, Assistant Director-General, Antimicrobial Resistance, World Health Organisation;
  • Professor Dame Sally Davies, lately Chief Medical Officer for England and newly-appointed UK Special Envoy on AMR for UK Government; and
  • Professor Brian Ferguson, Chief Economist, Public Health England.

There will be further contributions from: Doris-Ann Williams, BIVDA; Dr Jessica Boname, Medical Research Council; Dr Kitty Healey, Veterinary Medicines Directorate, DEFRA; Dr Roger Harrison, University of Manchester; Professor Hilary Thomas, Centre of Excellence in Healthcare and Life Sciences, KPMG and Rose Gallagher, Royal College of Nursing.

The chairs are Kevin Hollinrake and Lord Trees, Co-Chair, All-Party Parliamentary Group on Antibiotics and Co-Chair, All-Party Parliamentary Group on Animal Welfare.

The agenda in summary

  • Strengthening global coordination to tackle AMR;
  • Collaboration, encouraging innovation, and financial incentives for developing new antimicrobials;
  • Improving the prevention and control of infections, and assessing the public health benefits of tackling AMR;
  • Appropriate prescribing and reducing healthcare-associated infections - improving diagnostics, managing patient expectations, and engaging with clinicians, vets, and farmers; and
  • Next steps for meeting the goals of the UK AMR strategy.

Policymakers attending

Westminster Health Forum conferences typically attract strong interest from policymakers. This seminar will be an opportunity for stakeholders to engage with officials who have reserved places representing: DCMS; DEFRA; DHSC; DIT; HM Treasury; Government Legal Department; MHRA and Office for Life Sciences.

Price: £95 PLUS VAT

Shortly after every Westminster Health Forum seminar, a briefing document is produced. This is distributed to all delegates on the day as well as to our policymaker contacts in government, and to stakeholders more widely.

A seminar publication provides a timely record of proceedings, and acts as a guide to the latest thinking on current policy issues for those unable to be at the event.

This publication includes


Contributions from keynotes and panellists, including accompanying slides*
*Subject to approval

Delegate Pack

Information from the day, including delegate list, biographies and agenda


Transcript of questions and comments posed to speakers from attending delegates


Supplementary articles from speakers
and delegates